Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Health Evaluation in African Americans Using RAS Therapy

Authors not listed

Emory University · 2015

Abstract

The purpose of this study is to determine if telmisartan, an FDA approved blood pressure medication, may also have beneficial effects on Alzheimer's disease prevention in African Americans, who are at high risk for Alzheimer's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2015). Health Evaluation in African Americans Using RAS Therapy. <em>Emory University</em>. https://clinicaltrials.gov/study/NCT02471833
Vancouver
Anonymous. Health Evaluation in African Americans Using RAS Therapy. Emory University. 2015.
BibTeX
@misc{anon2015Health, title = {Health Evaluation in African Americans Using RAS Therapy}, author = {Anonymous}, journal = {Emory University}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings